Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Press Releases
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ROCHE HOLDING AG
07/22ROCHE : Half-year 2021 Investor Update
PU
07/22ROCHE : Half Year Report 2021
PU
07/22ROCHE : reports good half-year results - Investor Update
PU
07/22ROCHE : Half Year 2021 Presentation without appendix
PU
07/22ROCHE : Half Year 2021 Presentation with appendix
PU
07/22ROCHE : reports good half-year results
AQ
07/21ROCHE : FDA Grants Breakthrough Therapy Designation for Venclexta in Combination..
BU
07/20CHUGAI PHARMACEUTICAL : Antibody Cocktail, RONAPREVE for Intravenous Infusion Se..
AQ
07/20ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with ha..
AQ
07/20ROCHE : Japan becomes first country to approve Ronapreve (casirivimab and imdevi..
AQ
07/19ROCHE : New Data for Genentech's Hemlibra (emicizumab-kxwh) Reinforce Safety Pro..
BU
07/19ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with ha..
AQ
07/16REMINDER : Invitation to Roche's Half Year Results 2021 Presentation
PU
07/15CHUGAI PHARMACEUTICAL : Released Short Film Featuring Mayu Hotta and Nami Kishid..
AQ
07/12CHUGAI PHARMACEUTICAL : and Alebund Enter into Option and License Agreement for ..
AQ
07/09CHUGAI PHARMACEUTICAL : Disposal of Vaccines for Workplace Vaccination
AQ
07/09ROCHE : WHO guidelines now include Roche's diagnostic tests in expanded effort t..
AQ
07/08CHUGAI PHARMACEUTICAL : Files for Additional Indication of Tecentriq for the Adj..
AQ
07/02ROCHE : Media resources for Roche's 125 Years Anniversary
AQ
07/02ROCHE : to present new data at the ISTH 2021 Congress highlighting long-standing..
AQ
06/30ROCHE : Atea's AT-527, an oral antiviral drug candidate reduces viral replicatio..
PU
06/30SUPPORTING CANADA'S BACK TO NORMAL : Roche Diagnostics Canada introduces the new..
AQ
06/29CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission ..
AQ
06/28ROCHE : ENSPRYNG approved by European Commission as first and only at-home subcu..
AQ
06/25CHUGAI PHARMACEUTICAL : Genentech Announces FDA Emergency Use Authorization for ..
AQ
06/25ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibi..
AQ
06/25ROCHE : Invitation to Roche's Half Year Results 2021 Presentation
PU
06/25ROCHE : Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the ..
AQ
06/24GENENTECH : 's Actemra Receives FDA Emergency Use Authorization for the Treatmen..
BU
06/24PTC THERAPEUTICS : Evrysdi Approved in Japan for the Treatment of Spinal Muscula..
AQ
06/24ROCHE : Title test release to ensure the format looks goood
PU
06/24ROCHE : FDA accepts application for Roche's Port Delivery System with ranibizuma..
AQ
06/24ROCHE : FDA Accepts Application for Genentech's Port Delivery System With Ranibi..
BU
06/22Insulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
06/17ROCHE : Check You Employment Agreement's Restrictive Covenant
AQ
06/16ROCHE : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milesto..
AQ
06/15ROCHE : data at EAN 2021 showcase significant impact of therapies across diverse..
AQ
06/14CHUGAI PHARMACEUTICAL : Files New Drug Application in Japan for Faricimab, the F..
AQ
06/14PTC THERAPEUTICS : Pre-symptomatic Infants with Spinal Muscular Atrophy Achieved..
AQ
06/14ROCHE : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto co..
AQ
06/11GENENTECH : Announces Data at EHA2021 Reinforcing Efficacy of Venclexta Combinat..
BU
06/11ROCHE : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto co..
AQ
06/11ROCHE : New Roche data for Evrysdi show improved motor function in pre-symptomat..
AQ
06/11ROCHE : New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function ..
BU
06/09ROCHE : Accu-Chek® Inform II Hospital Blood Glucose System now approved by Healt..
AQ
06/08CHOROIDEREMIA PIPELINE : Emerging Therapies and Key pharma players involved by D..
AQ
06/08ROCHE : obtains CE mark for the SARS-CoV-2 Antigen Self Test Nasal allowing for ..
AQ
06/07REMINDER : Invitation to Roche's virtual event on key Evrysdi data presented at ..
PU
06/07ROCHE : Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin's..
AQ
06/07ROCHE : Dosage Regimens Affirmed In Canada Again
AQ
06/04GENENTECH : Presents Latest Advances With Immunotherapies in Non-Hodgkin's Lymph..
BU
06/04ROCHE : presents latest advances with immunotherapies in non-Hodgkin lymphoma
AQ
06/03ROCHE : Cancer Inclusion Into NHIs Would Reduce Economic Burden - Bagudu
AQ
06/03MEDULLOBLASTOMA PIPELINE : Emerging Therapies and Key pharma players involved by..
AQ
05/31REMINDER : Invitation to Roche's virtual event on key oncology data presented at..
PU
05/26ROCHE : Invitation to Roche's virtual event on key Evrysdi data presented at the..
PU
05/25ROCHE : European Commission approves Venclyxto-based combinations for adults wit..
AQ
05/21ONCOLYTICS BIOTECH : Announces Clinical and Biomarker Data Demonstrating Clinica..
AQ
05/20ROCHE : Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain ..
AQ
05/20ROCHE : Pivotal Phase III data at ASCO show Roche's Tecentriq helps certain peop..
AQ
05/19ROCHE : Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain ..
BU
05/18ROCHE : Diagnostics Canada partners with Canadian Blood Services to include Elec..
AQ
05/11PROTHENA : Announces achievement of $60 million milestone from roche for first p..
AQ
05/11ROCHE : to present data from one of the most comprehensive oncology portfolios a..
AQ
05/11GENENTECH : to Present Data From One of the Most Comprehensive Oncology Portfoli..
BU
05/10CHUGAI PHARMACEUTICAL : Discontinues Marketing of Photodynamic Diagnostic Agent ..
AQ
05/05ROCHE : Tecentriq approved by European Commission as a first-line monotherapy tr..
AQ
04/30ROCHE : Invitation to Roche's virtual event on key oncology data presented at AS..
PU
04/28ROCHE : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approva..
BU
04/28ROCHE : US FDA Advisory Committee votes in favour of maintaining accelerated app..
AQ
04/28ROCHE : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approva..
AQ
04/28ROCHE : launches new ways to use their cardiovascular tests empowering clinician..
AQ
04/27ROCHE : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approva..
BU
04/27ROCHE : US FDA Advisory Committee votes in favour of maintaining accelerated app..
AQ
04/26ABBVIE : Receives Positive CHMP Opinion for VENCLYXTO (venetoclax) as a Combinat..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ROCHE HOLDING AG